期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

低分子肝素Reviparin对ST段抬高急性心肌梗死患者死亡率、再梗死及脑卒中的效果

Effects of Reviparin, a Low-Molecular-Weight Heparin,on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation
暂未订购
导出
摘要 背景：尽管急性心肌梗死患者早期应用再灌注疗法，阿斯匹林、β-阻滞剂及血管紧张素转换酶抑制剂降低了死亡率，但其死亡率及发病率仍然是很高。尚无抗栓塞或较新的抗血小板药物被证实可降低急性心肌梗死的死亡率。
作者 无 徐成斌（译）
机构地区 The CREATE Trial Group Investigators 不详
出处 《美国医学会杂志（中文版）》 2006年第2期75-83,共9页 The Journal of the American Medical Association(Chinese Edition)
关键词 急性心肌梗死 心肌梗死患者 死亡率 ST段抬高 低分子肝素 血管紧张素转换酶抑制剂 脑卒中 再梗死 抗血小板药物 再灌注疗法
分类号 R542.22 [医药卫生—心血管疾病] R743 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献26

  • 1Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases, part h general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001 ;104:2746-2753.
  • 2ISIS-2 (Second International Study of infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
  • 3Fibrinolytic Therapy Trialists' (FFT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of eady mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet.1994;343:311-322.
  • 4ISIS-1 (First International Study of Infarct Survival)Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet. 1986;2:57-66.
  • 5ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopdl, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction,Lancet. 1995;345:669-685.
  • 6Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials, Lancet. 2003;361:13-20.
  • 7The GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein Ⅱb/Ⅲa inhibition: the GUSTO V randomised trial. Lancet. 2001 ;357:1905-1914.
  • 8The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abdximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 2001 ;358:605-613
  • 9Direct Thrombin Inhibitor Trialists' Collaborative Group. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data. Lancet. 2002;359:294-302.
  • 10The Hirulog and Early Reperfusion or Occlusion(HERO)-2 Trial Investigators. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet.2001 ;358:1855-1863.
美国医学会杂志（中文版）
2006年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部